Systematic review links diabetes to impaired immune control of tuberculosis pathogenesis across 81 studies
Diabetes changes how the body fights tuberculosis infection in humans and animals
This systematic review synthesizes evidence from 81 eligible studies involving animal models and human participants to examine how diabetes …
A review of 81 studies shows diabetes weakens the immune system, making tuberculosis worse and harder to control in people and lab animals.
Narrative review links microgravity exposure to altered fat distribution and inflammation in metabolic disease models
How Space Travel Is Unlocking New Ways to Fight Obesity and Diabetes
This narrative review synthesizes evidence from human studies, animal models, and in vitro experiments regarding microgravity and metabolic …
This research shows that the same health problems astronauts face in space are happening to people on Earth who sit too much, and it may lea…
Combination valsartan and dapagliflozin improves blood pressure and glucose in Type 2 Diabetes and hypertension
Two Common Heart and Kidney Drugs Work Better Together Than Alone
This retrospective cohort study of 245 patients with coexisting Type 2 Diabetes Mellitus and hypertension found that combination therapy wit…
For patients with diabetes and high blood pressure, combining two common medications may offer stronger protection for the heart and kidneys…
Biochemical remission of Cushing's syndrome reduces hepatic steatosis and fibrosis indices in adult patients
Cushing’s Syndrome Often Leads to Fatty Liver Disease
This retrospective cohort study evaluated 126 adult patients with endogenous Cushing's syndrome (CS).
New findings reveal fatty liver is common in Cushing’s syndrome, yet liver fat may improve after treatment ends, offering hope for patients.
High 1-mg DST, low PNI, diabetes, and poor bone health predict infection in Cushing syndrome surgery
High Cortisol Levels Signal Higher Infection Risk Before Surgery
This retrospective single-center cohort study evaluated 113 patients with confirmed Cushing syndrome.
Doctors can now spot patients at high risk for surgery infections days before the operation starts.
CGM-Derived Glycemic Persistence Index Predicts OGTT 2-Hour Glucose in Dysglycemia
Wearable Glucose Monitor Could Replace Burdensome Blood Test
In an observational cohort of adults with paired free-living CGM and OGTT, the glycemic persistence index (GPI) was the strongest single pre…
A new way to read glucose monitor data might make testing easier.
MCH1 Receptor Antagonist RGH-706 Shows Weight Loss in Preclinical and Early Clinical Study
New Drug Targets Hunger Brain Signals to Help Shed Pounds
A preclinical and phase I/II study evaluated the MCH1 receptor antagonist RGH-706 for obesity and Prader-Willi Syndrome.
Scientists found a new medicine that may help people lose weight by turning off hunger signals.
Longitudinal ABCD Study links central fat dynamics to cognitive deficits in adolescents
How Fat Gain in Teens Changes the Brain’s Wiring
This longitudinal observational study from the Adolescent Brain Cognitive Development (ABCD) Study analyzed central fat dynamics in 8,519 ad…
Your teen’s brain is still building itself.
FDA Approves Tzield (teplizumab) to Delay Onset of Stage 3 Type 1 Diabetes
FDA approves Tzield to delay type 1 diabetes in high-risk patients
The FDA approved Tzield (teplizumab) to delay the onset of Stage 3 type 1 diabetes in patients aged 1 year and older with Stage 2 disease.
The FDA approved Tzield (teplizumab) to delay the onset of stage 3 type 1 diabetes in people aged 1 and older with stage 2 disease.
Meta-analysis of sex differences in insulin therapy outcomes for adults with Type 1 and Type 2 diabetes
Women and Men Respond Differently to Insulin Therapy
This systematic review and meta-analysis evaluated sex differences in insulin therapy outcomes across 24 studies involving adults with Type …
Maria takes insulin every day for type 2 diabetes.
GZR18 showed weight loss in Chinese adults with overweight or obesity in a phase 1b/2a trial
New Drug Cuts Weight by Nearly 20% in Just 35 Weeks
In this randomized, placebo-controlled phase 1b/2a trial, 60 Chinese adults with overweight or obesity received GZR18 or placebo.
This new treatment shows huge promise for helping people reach their weight goals without daily pills.
Systematic review of endocrine-disrupting chemicals and neurotoxic effects in zebrafish
Common Chemicals May Quietly Rewire Your Brain and Nerves
This systematic review synthesizes evidence from 12 studies on endocrine-disrupting chemicals (EDCs) in zebrafish.
Everyday chemicals found in plastics and pesticides may harm brain development and nerve function in ways that can last for generations.